OKYO Pharma CMO Flavio Mantelli Receives 20,000-Share Award

What Happened Flavio Mantelli, Chief Medical Officer of OKYO Pharma Ltd (OKYO), was granted 20,000 shares on July 21, 2026. The award was recorded at $1.40 per share, for a total reported value of $28,000. This transaction is an equity award/grant (Form 4 transaction code A), an acquisition of shares as part of compensation rather than an open-market purchase.

Key Details

• Transaction date: 2026-07-21; filing date: 2026-07-22 (timely filing the next day).
• Price reported: $1.40 per share; total value: $28,000 for 20,000 shares.
• Shares owned after transaction: not specified in the provided filing summary.
• Footnotes: no 10b5-1 plan, tax withholding, or other special footnotes were indicated in the filing summary provided.
• SEC filing accession: 0001493152-26-034236 (Form 4).

Context Equity awards like this are commonly part of executive compensation (restricted stock, RSUs, or similar) and reflect compensation decisions rather than direct open-market buying or selling. Such grants can be informative about company pay practices but do not by themselves indicate the insider’s personal market view.